Brief: CNS Pharmaceuticals Reports Third Quarter 2022 Financial Results
14/11/2022 21:37
Nov 14 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* CNS PHARMACEUTICALS - CURRENT EXPECTATION IS THAT CASH ON
HAND
AND PROCEEDS FROM OFFERING DURING JAN IS SUFFICIENT TO FUND OUR
OPERATIONS INTO Q1 2023
Source text for Eikon: ID:nPn7Q8rbfa
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026